# Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function

> **NCT02307045** · PHASE4 · UNKNOWN · sponsor: **University of Athens** · enrollment: 600 (estimated)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline
- **DRUG:** nicotine

## Key facts

- **NCT ID:** NCT02307045
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12-03
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307045, "Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02307045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*